Disclaimer: This is an example of a student written essay.
Click here for sample essays written by our professional writers.

Any scientific information contained within this essay should not be treated as fact, this content is to be used for educational purposes only and may contain factual inaccuracies or be out of date.

Estimation of Tranexamic Acid Andethamsylate Using RP-HPLC

Paper Type: Free Essay Subject: Chemistry
Wordcount: 4830 words Published: 28th Nov 2017

Reference this

Chapter-3 Experimental work

3. EXPERIMENTAL WORK

3.1 MATERIALS AND METHODS

Table 2. List of Chemical and standers used

S.No

Chemicals

Manufacturer Name

Grade

1

Water

Processed in Bright Labs

HPLC grade

2

Acetonitrile

Fisher scientific

HPLC grade

3

Orthophosphoric acid

Merck

GR grade

4

Tranexamic acid

Sun pharma ltd

BP

5

Ethamsylate

Sun pharma ltd

USP

6

KH2PO4

Merck

GR grade

7

K2HPO4

Merck

GR grade

8

Methanol

Merck

HPLC grade

Table 3. List of instruments used

S.No

Instrumentname

Model

Number

Soft

Ware

Manufacturers name

1

HPLC-auto

sampler-UV detector

ACME9000

Auto crome 3000

Youngline

2

Electronic balance

Lab India

3

Sonicator

CWUC9L

201402822

Spectrum tek

4

Vacuum Pump

28965405-289717

Vacuubrand

5

0.45µ filter paper

HPLC grade

Rankem

3.2. Method development for the simultaneous estimation of Tranexamic acid andethamsylate by using RP-HPLC.

  1. Selection of mobile phase
  2. Selection of detectionwavelength
  3. Selection of column
  4. Selection of solvent delivery system
  5. Selection of flow rate
  6. Selection of column temperature
  7. Selection of diluent
  8. Selection of test concentration and injection volume

3.2.1. Selection of mobile phase

Phosphate Buffer: Methanol (30:70)

3.2.2. Selection of wavelength

10mg Tranexamic acid and Ethamsylate were dissolved in mobile phase. The overlay spectrum was used for selection of wavelength for Tranexamic acid and Ethamsylate The iso-bestic point was taken as detection wavelength 286nm.

3.2.3. Selection of column

  • Heart of HPLC made of 316 grade stainless steel packed with stationary phase.

Silica based columns with different cross linking’s in the increasing order of polarity are as follows:

——- Non-polar———-moderately polar——–Polar———-

C18< C8< C6< Phenyl < Amino

  • In reverse phase chromatography, hydrophobic interaction between drug molecule and the alkyl chains on the column packing material.
  • Column is selected based on solubility, polarity & chemical differences among analytes and Column selected: i.e. X-Bridge C18 (150 × 4.6 mm, packed with 5 µm), particle size
  • Reasons: Better separation,

    Good tailing factor.

    3.2.4. Selection of solvent delivery system

    • Always preferable solvent delivery system.
    • More chance of getting reproducible result on retention time of analytes.
    • More economic than gradient technique.

    3.2.5. Selection of flow rate

    Acceptable limit: – Not more than 2.5 ml/min

    • Flow rate selected was 1.0ml/min
    • Flow rate is selected based on

    1. Retention time

    2. Column back pressure

    3. Peak symmetry.

    4. Separation of impurities.

    Reasons:

    • For earlier elution of analyte and elution of all impurities within 10 min
    • Information from the reference method in literature.

    3.2.6. Selection of diluent

    • Selection of diluents is based on the solubility of the analyte
    • Diluent selected: Phosphate Buffer: Methanol (30:70 % v/v)

    Reason:

    • Analyte is soluble in acetonitrile and water.

    3.2.7. Selection of column temperature

    • Preferable temperature is ambient or room temperature.

    Reasons:

    • To elute all impurities along with analyte with in 10 min of run time.
    • Less retention time
    • Good peak shape
    • Higher theoretical plates.
    • Good resolution.

    3.2.8. Selection of test concentration and injection volume

    Test concentration is finalized after it is proved that API is completely extractable at the selected test concentration.

    • Test concentration is fixed based upon the response of API peak at selected detector wavelength.
    • Tranexamic Acid and Ethamsylate label claimed 25mg and 50 mg
    • And the test concentration selected is 100ppm
    • Injection volume selected is 20µL.

    Reason: good peak area, retention time, peak symmetry

    Chromatographic trails for simultaneous estimation Tranexamic acid Ethamsylate

    TRIAL 1

    Parameters

    Method

    Stationary phase (column) :

    Kromosil C18 (150 × 4.6 mm, packed with 5 µm)

    Mobile Phase :

    100% of Methanol

    Ph :

    3.0 ± 0.02

    Flow rate (ml/min) :

    1.0

    Run time (minutes) :

    8.0

    Column hotness (°C) :

    Ambient

    Volume of injection loop (l) :

    20

    Detection wavelength (nm) :

    242

    Drugs RT (min) :

    2.91 & 4.42

    Fig. 4: Trial 1

    S.No.

    Name

    RT[min]

    Area[µV*s]

    TP

    TF

    Resolution

    1

    Tranexamic Acid

    2.9167

    491583

    7707.5

    1.0833

    0.0000

    2

    Ethamsylate

    4.4227

    1076649

    10124.7

    1.0124

    5.3676

    Sum

       

    1568232

         

    Observation: 100% Methanol used for this trial, flow rate was 1ml/min at ambient temperature. Faster elution of the analyte takes place .

    TRIAL 2

    Parameters

    Method

    Stationary phase (column) :

    Inertsil C18 (250 × 4.6 mm, packed with 5 µm)

    Mobile Phase :

    30:70 (Methanol : water)

    Ph :

    3.5 ± 0.02

    Flow rate (ml/min) :

    1.0

    Run time (minutes) :

    8.0

    Column temperature (°C) :

    Ambient

    Volume of injection loop (l) :

    20

    Detection wavelength (nm) :

    228

    Drugs RT (min) :

    2.81 & 5.34

    Fig. 5: Trial 2

    S.No.

    Name

    RT[min]

    Area[µV*s]

    TP

    TF

    Resolution

    1

    Tranexamic Acid

    2.8167

    1272583

    4707.5

    1.0333

    0.0000

    2

    Ethamsylate

    5.3467

    1952369

    9124.7

    1.0524

    7.1376

    Sum

       

    3224952

         
                 

    Observation: Methanol and water was used in the ratio of 70:30. The flow rate was 1ml/min at ambient temperature.Couldn’t get consistent retention time

    TRIAL 3

    Parameters

    Method

    Stationary phase (column) :

    Inertsil C18 (250 × 4.6 mm, packed with 5 µm)

    Mobile Phase :

    30:70 (Methanol : Phosphate Buffer)

    Ph :

    3.0 ± 0.02

    Flow rate (ml/min) :

    1.0

    Run time (minutes) :

    15.0

    Column temperature (°C) :

    Ambient

    Volume of injection loop (l) :

    20

    Detection wavelength (nm) :

    236

    Drugs RT (min) :

    2.86 & 10.48

    Fig. 6: Trial 3

    S.No.

    Name

    RT[min]

    Area[µV*s]

    TP

    TF

    Resolution

    1

    Tranexamic Acid

    2.8627

    407583

    2307.5

    1.2833

    0.0000

    2

    Ethamsylate

    10.4802

    9792049

    9901.7

    1.3124

    10.2646

    Sum

       

    10199632

         

    Observation: Methanol and Phosphate Buffer used in the ratio of (30:70 ) Couldn’t get consistent retention time

    Discussion: The above trials indicating that RT for the drug was not constant and elution time was faster which not prefered for the analysis.

    TRAIL 4

    Optimizing method

    Parameters

    Method

    Stationary phase (column) :

    X-Bridge C18 (150 × 4.6 mm, packed with 5 µm)

    Mobile Phase :

    30:70 (Phosphate Buffer : Methanol)

    pH :

    3.2 ± 0.02

    Flow rate (ml/min) :

    1.0

    Run time (minutes) :

    8.0

    Column temperature (°C) :

    Ambient

    Volume of injection loop (l) :

    20

    Detection wavelength (nm) :

    286

    Drugs RT (min) :

    3.01 & 5.06

    Fig. 7: Developed Chromatogram

    S.No.

    Name

    RT[min]

    Area[µV*s]

    TP

    TF

    Resolution

    1

    Tranexamic Acid

    3.0167

    1574827

    3707.5

    1.0833

    0.0000

    2

    Ethamsylate

    5.0667

    2779277

    5124.7

    1.0124

    8.5376

    Sum

       

    4354104

         

    Discussion: All the experiments were complete by the higher than developed method and the consequences were acceptable.

    Optimized chromatographic conditions for simultaneous estimation of Tranexamic Acid and Ethamsylate

    Trail 4: (Optimized Chromatographic Conditions)

    Parameters

    Method

    Stationary phase (column) :

    X-Bridge C18 (150 × 4.6 mm, packed with 5 µm)

    Mobile Phase :

    30:70 (Phosphate Buffer : Methanol)

    PH :

    3.2 ± 0.02

    Flow rate :

    1.0

    Run time (min) :

    8.0

    Column temperature (°C) :

    Ambient

    Volume of injection loop (l) :

    20

    Detection wavelength (nm) :

    286

    Drugs RT (min) :

    3.01 & 5.06

    Assay procedure

    Preparation of 0.2M phosphate buffer:

    Buffer solution prepares by dissolving 2.72g of Potassium dihydrogen ortho phosphate (KH2PO4) in 1L of water and the degassing of the solution.

    Diluents Preparation:

    1L of diluents was prepared by mixing 300 ml of 0.02 M Phosphate Buffer and 700 ml of Methanol.

    Preparation of stock solution:

    Accurately weighed 10 mg of the both Tranexamic Acid and Ethamsylate is transferred to 10 ml fresh and dry volumetric flask. The amount was making up to the mark among the Methanol and mixed well. This yielded a stock solution with concentration 1000 ppm of Tranexamic Acid and Ethamsylate mixture.

    Preparation of standard solution:

    Accurately amount of 0.25 and 0.25 ml of the Tranexamic Acid and Ethamsylate stock solution transferred to 10 ml clean and dried volumetric flask. Then compose up the amount up to the mark among the diluents and mix well. Finally the standard stock solution with concentrations of 25 ppm and 25 ppm of Tranexamic Acid and Ethamsylate respectively.

    Procedure

    20Lof the standard and sample was injected into the chromatographic system and areas for the Tranexamic acid and Ethamsylate from the peaks were used for calculating the % assay by using the formulae.

    Assay calculation

    AT WS DT P Avg. Wt

    Assay % =————– x ———-x ——— x ———-x—————— 100

    AS DS WT 100 Label Claim

    Where:

    AT = Average area counts of sample preparation.

    AS = Average area counts of standard preparation.

    WS=Weight of working standard taken in mg.

    P= Percentage purity of working standard

    LC = Label Claim of Tranexamic acid , Ethamsylate mg/ml.

    3.4 METHOD VALIDATION

    3.4.1 ANALYTICAL METHOD VALIDATION

    Validation parameters

    • Specificity
    • Linearity
    • Range
    • Accuracy
    • Precision
      • System precision
      • Repeatability
      • Intermediate Precision
    • Detection Limit
    • Quantitation Limit
    • Robustness

    1. Specificity

    The system suitability for specificity was carried out to determine whether there are any interference of any impurities in retention time of analytical peak. The study was performed by injecting blank.

    2. Linearity

    The linearity is a systematic method its ability (within a given range) to get assessment results, which are directly relative to the absorption (amount) of analyte in sample.

    Preparation of standard stock solution:

    Accurately weighed 10 mg of the both tranexamic acid and Ethamsylate was transferred in to 10 ml fresh and dry volumetric flask.

    After that the amount was made up to the mark with the Methanol and mix well. This yielded a stock solution amid attention 1000 ppm of tranexamic acid with Ethamsylate mixture.

    Preparation of standard solution:

    Accurately amount of 0.25 and 0.25 ml of the tranexamic acid and Ethamsylate stock was transferred to 10 ml clean and dry volumetric flask. Then the volume was made up to the mark with the diluent and mixed well. This yielded a standard stock solution with concentrations of 25ppm and 25ppm of tranexamic acid and Ethamsylate respectively10

    Procedure: Prepared a series of standard solutions not less than five during the particular concentration range along with investigate them like for each method.

    Acceptance criteria: The correlation coefficient should be not less than 0.9990

    3. Range

    The range of a systematic process is the gap between the superior and lower concentration of analyte in sample for which it has been established to the investigative practice was a suitable level of accuracy, precision and linearity.

    Acceptance criteria: Linearity, Precision and Recovery should be shown.

    The logic behind this parameter was – typical concentration range was essential between which the actual concentration should fall when performing real sample analysis.10

    4. Accuracy

    Preparation of standard stock solution:

    Accurately amount of 0.25 and 0.25 ml of the tranexamic acid and Ethamsylate stock solution transfer to 10 ml fresh and dried volumetric flask. Make up the volume up to mark with the diluents and mix well. The standard stock solution with concentrations of 25 ppm and 25 ppm of tranexamic acid and Ethamsylate respectively.

    Method procedure: Prepared solutions in triplicate at levels 80%, 100% and 120s% of test concentrations using for tranexamic acid and Ethamsylate working Standards as per the test method and injected each solution in triplicate.

    Sample Are 100

    % Recovery = ———————– x —————— x 100

    Standared Area conc. in %

    Accuracy normally refers to the difference between the mean of the set of results and the true or correct value for the quantity measured. According to IUPAC accuracy relates to the difference between results (or mean) and the true value. For analytical methods, there are two possible ways of determining the accuracy, absolute method and comparative method. Accuracy is best reported as percentage bias, which is calculated from the expression

    Procedure: Known amount of drug substance spiked with known amount of standard drug- minimum of three levels (80%, 100% & 120% of test concentration), each level was triplicate.

    Acceptance criteria: Assay recovery should be between 97%-103%.10

    5. Precision

    Preparation of standard solution:

    Accurately amount of 0.25 and 0.25 ml of the tranexamic acid and Ethamsylate stock solution transferred to 10 ml clean and dried volumetric flask.

    Subsequently make up the volume up to the mark among the diluent and well mixed. Finally the standard stock solution with concentrations of 25 ppm and 25 ppm of tranexamic acid and Ethamsylate respectively.

    Method precision: Six individual preparations were prepared using single batch of tranexamic acid and Ethamsylate functioning standard as for each test process and injected each one solutions.

    Injection precision:

    Solo preparation was prepared using single batch of Tranexamic acid and Ethamsylate effective standard as for each urbanized process in addition to injected six injections10.

    Acceptance Criteria:

    1. RSD should not be more than 2.0% for five replicate injections of standard.

    6. Ruggedness

    Preparation of standard solution:

    Accurately amount of 0.25 and 0.25 ml of the tranexamic acid and Ethamsylate stock solution transferred to 10 ml clean and dried volumetric flask. Subsequently make up the quantity up to the mark among the diluents and well mix. Finally the standard stock solution with concentrations of 25 ppm and 25 ppm of tranexamic acid and Ethamsylate respectively.

    Method Procedure: The standard solution was individually prepared as per the test method and injected each solution in six times using different system, analyst, and date.

    Acceptance Criteria: Overall RSD should not be more than 2.0 %.

    7. Limit detection and limit of quantitation

    LOD: Lowest amount of analyte in a sample that can be detected but not necessarily quanities, under the stated experimental conditions.

    Preparation of standard solution:

    Accurately amount of 0.25 and 0.25 ml of the tranexamic acid and Ethamsylate stock solution transferred to 10 ml clean and dried volumetric flask. Then build up the quantity up to the mark with the diluents and mix well. Finally the standard stock solution with concentrations of 25 ppm and 25 ppm of Tranexamic acid and Ethamsylate respectively.

    Method Procedure:

    The mobile phase was permissible to run equilibrate with stationary phase up to good baseline was obtained. The different concentration ranging from 0.01 to 0.1ppm of tranexamic acid and 0.01 to 0.1ppm Ethamsylate was injected and peaks were recorded. 0.03 and 0.03ppm for tranexamic acid and Ethamsylate concentrations were detected respectively.

    LOD can be calculated based on signal-noise ratio,by using following formula

    LOD = S/N

    Where,

    S = Signal Obtained From LOD Solution.

    N = Average Baseline Noise Obtained from Blank

    Acceptance criteria for LOD and LOQ

    RSD Criteria

    Concentration at which RSD < 44.0% (LOD)

    Concentration at which

    RSD<10.0 (LOQ)

    8. Robustness

    Preparation of standard solution:

    Accurately amount of 0.25 and 0.25 ml of the tranexamic acid and Ethamsylate stock solution transferred to 10 ml clean and dried volumetric flask. After that make up the quantity up to the mark with diluent and well mixed. Finally the standard stock solution with concentrations of 25 ppm and 25 ppm of tranexamic acid and Ethamsylate respectively.

    Method procedure:

    1. Flow: The standard solution was prepared and injected for the two times with (+1) flow rate.

    2. Mobile Phase: The standard solution was prepared and injected for the two times with (+5) Mobile Phase composition.

    Appraise of its capability to remain unchanged by minute, but conscious variations in process parameters and provides signal of its reliability during its normal usage.

    Procedure: samples were analyzed under the following conditions.10

    3. Stability studies

    In the rational design and evaluation of dosage forms for the drugs, the stability of the activity components must be a major criterion in determining their stability. The medicine has to reach the patient in an active and acceptable form maintaining the criteria for acceptable equality.

    The quality of the product has to be retained as long as the product is offered for sale or for administration to the patient. 10

    Acceptance Criteria: Overall RSD should not be more than 2.0 %.

    9. System suitability

    Preparation of standard solution:

    Accurately amount of 0.25 and 0.25 ml of the tranexamic acid and Ethamsylate stock solution transferred to 10 ml clean and dried volumetric flask. Subsequently make up the amount up to the mark with diluent and well mixed.

    Finally the standard stock solution with concentrations of 25 ppm and 25 ppm of tranexamic acid and Ethamsylate respectively.

    Procedure: Standard solution was prepared and injected six times to test the performance of the chromatographic instrument.

    Acceptance Criteria:

    1. RSD should not be more than 2.0% for five replicate injections of standard

    2. USP Tailing for tranexamic acid and Ethamsylate peak in not more than 2.0

    3. The column efficiency as determined for tranexamic acid and ethamsylate

    Plate Count should not be more than 2000.

    Dept.of Pharmaceutical Analysis JNTUA-OTRI, Ananthapuramu Page 1

     

    Cite This Work

    To export a reference to this article please select a referencing stye below:

    Reference Copied to Clipboard.
    Reference Copied to Clipboard.
    Reference Copied to Clipboard.
    Reference Copied to Clipboard.
    Reference Copied to Clipboard.
    Reference Copied to Clipboard.
    Reference Copied to Clipboard.

    Related Services

    View all

    DMCA / Removal Request

    If you are the original writer of this essay and no longer wish to have your work published on UKEssays.com then please: